Ads
related to: Dupixent- Pricing And Insurance
Check Copay Eligibility
Learn About Payment Options
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Patient Support
Access DUPIXENT MyWay®
Get Patient Journey Support Today
- Injection Support Center
Get Help With Taking DUPIXENT®
View Injection Resources Now
- Pricing And Insurance
Search results
Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
Zacks via Yahoo Finance· 2 years agoSanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
Sanofi's (SNY) Dupixent Gets FDA Nod for Eczema in Infants
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) and partner Regeneron's label expansion application for Dupixent to include infants...
Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis
Zacks via Yahoo Finance· 1 year agoThe CHMP recommends approval of Sanofi (SNY) and partner Regeneron's Dupixent for the treatment of...
FDA Accepts Sanofi's (SNY) sBLA for Dupixent in Pediatric EoE
Zacks via Yahoo Finance· 6 months agoIf this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved...
Sanofi's Dupixent gets U.S. approval to treat eczema in young children
Reuters via Yahoo News· 2 years agoDupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
Benzinga via Yahoo Finance· 10 months agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) presented results from a...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters via Yahoo News· 12 months ago(Reuters) -Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung",...
US FDA approves Dupixent to treat younger kids with esophageal condition
Reuters via Yahoo News· 2 months ago(Reuters) -The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to...
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool· 2 years agoOn May 20, the U.S. Food and Drug Administration (FDA) approved Sanofi (NASDAQ: SNY) and Regeneron's...
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Motley Fool· 12 months agoRecently, Sanofi (NASDAQ: SNY) and Regeneron (NASDAQ: REGN) received positive news from the U.S....
Ads
related to: Dupixent